Gagnon Securities LLC Celcuity Inc. Transaction History

Gagnon Securities LLC

  • $463 Million
  • Q4 2024

A detailed history of Gagnon Securities LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Gagnon Securities LLC holds 52,479 shares of CELC stock, worth $534,236. This represents 0.15% of its overall portfolio holdings.

Number of Shares
52,479
Previous 52,793 0.59%
Holding current value
$534,236
Previous $787,000 12.83%
% of portfolio
0.15%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025
SELL
$12.0 - $16.35 $3,768 - $5,133
-314 Reduced 0.59%
52,479 $686,000
Q3 2024

Nov 12, 2024
SELL
$13.98 - $19.15 $5,578 - $7,640
-399 Reduced 0.75%
52,793 $787,000
Q2 2024

Aug 14, 2024
SELL
$14.1 - $20.78 $4,765 - $7,023
-338 Reduced 0.63%
53,192 $871,000
Q1 2024

May 13, 2024
SELL
$13.74 - $21.6 $6,595 - $10,368
-480 Reduced 0.89%
53,530 $1.16 Million
Q3 2023

Nov 14, 2023
BUY
$8.96 - $10.75 $2,607 - $3,128
291 Added 0.54%
54,010 $493,000
Q2 2023

Aug 08, 2023
SELL
$9.39 - $12.18 $2,845 - $3,690
-303 Reduced 0.56%
53,719 $589,000
Q1 2023

Apr 10, 2023
SELL
$9.4 - $12.82 $5,950 - $8,115
-633 Reduced 1.16%
54,022 $553,000
Q4 2022

Feb 07, 2023
SELL
$7.55 - $14.01 $203,834 - $378,241
-26,998 Reduced 33.06%
54,655 $765,000
Q3 2022

Nov 14, 2022
SELL
$8.0 - $10.64 $1.82 Million - $2.42 Million
-227,829 Reduced 73.62%
81,653 $820,000
Q2 2022

Aug 01, 2022
SELL
$5.35 - $10.11 $8,260 - $15,609
-1,544 Reduced 0.5%
309,482 $2.82 Million
Q1 2022

May 09, 2022
BUY
$7.93 - $13.33 $36,731 - $61,744
4,632 Added 1.51%
311,026 $2.91 Million
Q4 2021

Feb 08, 2022
SELL
$11.96 - $19.35 $6,625 - $10,719
-554 Reduced 0.18%
306,394 $4.04 Million
Q3 2021

Nov 12, 2021
SELL
$17.35 - $24.87 $214,428 - $307,368
-12,359 Reduced 3.87%
306,948 $5.53 Million
Q2 2021

Jul 28, 2021
SELL
$14.25 - $30.93 $1.35 Million - $2.94 Million
-94,985 Reduced 22.93%
319,307 $7.66 Million
Q1 2021

May 14, 2021
BUY
$10.43 - $17.8 $522,282 - $891,335
50,075 Added 13.75%
414,292 $5.94 Million
Q4 2020

Feb 12, 2021
BUY
$5.13 - $11.72 $5,478 - $12,516
1,068 Added 0.29%
364,217 $3.34 Million
Q3 2020

Nov 12, 2020
SELL
$5.1 - $7.07 $6,069 - $8,413
-1,190 Reduced 0.33%
363,149 $2.11 Million
Q2 2020

Aug 13, 2020
BUY
$4.42 - $11.04 $740,182 - $1.85 Million
167,462 Added 85.06%
364,339 $2.53 Million
Q1 2020

May 11, 2020
BUY
$5.79 - $11.78 $147,905 - $300,920
25,545 Added 14.91%
196,877 $1.28 Million
Q4 2019

Feb 14, 2020
BUY
$9.47 - $16.71 $3,560 - $6,282
376 Added 0.22%
171,332 $1.82 Million
Q3 2019

Nov 08, 2019
SELL
$15.74 - $23.65 $27,230 - $40,914
-1,730 Reduced 1.0%
170,956 $2.9 Million
Q2 2019

Aug 12, 2019
BUY
$19.88 - $25.0 $19,223 - $24,175
967 Added 0.56%
172,686 $4.32 Million
Q1 2019

May 13, 2019
SELL
$18.38 - $24.44 $57,198 - $76,057
-3,112 Reduced 1.78%
171,719 $3.76 Million
Q4 2018

Jan 18, 2019
SELL
$20.87 - $29.05 $375,680 - $522,929
-18,001 Reduced 9.34%
174,831 $4.19 Million
Q3 2018

Nov 13, 2018
SELL
$20.96 - $30.77 $112,869 - $165,696
-5,385 Reduced 2.72%
192,832 $5.55 Million
Q2 2018

Aug 09, 2018
SELL
$16.13 - $26.99 $181,785 - $304,177
-11,270 Reduced 5.38%
198,217 $4.92 Million
Q1 2018

May 09, 2018
SELL
$13.55 - $21.3 $170,811 - $268,507
-12,606 Reduced 5.68%
209,487 $3.45 Million
Q4 2017

Feb 13, 2018
SELL
$12.12 - $21.65 $29,924 - $53,453
-2,469 Reduced 1.1%
222,093 $4.21 Million
Q3 2017

Nov 14, 2017
BUY
$11.94 - $14.29 $2.68 Million - $3.21 Million
224,562
224,562 $2.75 Million

Others Institutions Holding CELC

# of Institutions
104
Shares Held
30M
Call Options Held
17.5K
Put Options Held
100
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $152M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Gagnon Securities LLC Portfolio

Follow Gagnon Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email